212 related articles for article (PubMed ID: 16093428)
1. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
[TBL] [Abstract][Full Text] [Related]
2. Activation of a local tissue angiotensin system in podocytes by mechanical strain.
Durvasula RV; Petermann AT; Hiromura K; Blonski M; Pippin J; Mundel P; Pichler R; Griffin S; Couser WG; Shankland SJ
Kidney Int; 2004 Jan; 65(1):30-9. PubMed ID: 14675034
[TBL] [Abstract][Full Text] [Related]
3. p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton.
Martineau LC; McVeigh LI; Jasmin BJ; Kennedy CR
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F693-701. PubMed ID: 14665434
[TBL] [Abstract][Full Text] [Related]
4. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
[TBL] [Abstract][Full Text] [Related]
6. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress.
Endlich N; Sunohara M; Nietfeld W; Wolski EW; Schiwek D; Kränzlin B; Gretz N; Kriz W; Eickhoff H; Endlich K
FASEB J; 2002 Nov; 16(13):1850-2. PubMed ID: 12354696
[TBL] [Abstract][Full Text] [Related]
7. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes.
Faour WH; Thibodeau JF; Kennedy CR
Cell Signal; 2010 Aug; 22(8):1222-30. PubMed ID: 20362052
[TBL] [Abstract][Full Text] [Related]
9. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
10. Mechanical stretch induces podocyte hypertrophy in vitro.
Petermann AT; Pippin J; Durvasula R; Pichler R; Hiromura K; Monkawa T; Couser WG; Shankland SJ
Kidney Int; 2005 Jan; 67(1):157-66. PubMed ID: 15610239
[TBL] [Abstract][Full Text] [Related]
11. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
12. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
13. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
14. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
15. SPARC accelerates disease progression in experimental crescentic glomerulonephritis.
Sussman AN; Sun T; Krofft RM; Durvasula RV
Am J Pathol; 2009 May; 174(5):1827-36. PubMed ID: 19342370
[TBL] [Abstract][Full Text] [Related]
16. How many ways can a podocyte die?
Tharaux PL; Huber TB
Semin Nephrol; 2012 Jul; 32(4):394-404. PubMed ID: 22958494
[TBL] [Abstract][Full Text] [Related]
17. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
Wanke R; Wolf E; Brem G; Hermanns W
Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
[TBL] [Abstract][Full Text] [Related]
18. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
19. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
[TBL] [Abstract][Full Text] [Related]
20. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
Mitu GM; Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
